Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's extensive portfolio includes intravenous generic drugs, infusion therapies, and clinical nutrition products, alongside the medical devices required for their administration. A core component of their delivery technology is the freeflex® IV bag, a proprietary, multilayer polyolefin container system designed to be PVC-free, DEHP-free, and latex-free to ensure maximum patient and clinician safety. Beyond infusion containers, the company is a major player in the biosimilars market, developing and commercializing treatments for oncology and autoimmune diseases. Fresenius Kabi operates as a key business segment of the Fresenius SE & Co. KGaA group, maintaining a significant global manufacturing and R&D footprint. Their products are essential in critical care settings, helping to treat chronically and critically ill patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Freeflex IV Bags.